Transcatheter Pulmonary Valve Market Size & Growth Forecast 2027–2036, By Segments (End-use, Raw Material, Technology, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Transcatheter Pulmonary Valve Market size was valued at USD 80.8 million in 2026 and is anticipated to grow at a 5.23% CAGR from 2027 to 2036, crossing USD 134.53 million by 2036. The industry revenue for 2027 is assessed at USD 84.36 million.
Get more details on this report
Request Free Sample ReportTranscatheter Pulmonary Valve Market Intelligence Snapshot
Regional Market Dynamics
- North America led the market in 2026, supported by specialized cardiac centers, established structural heart intervention programs, experienced clinicians, and coordinated care pathways for transcatheter valve procedures.
- Asia Pacific is projected to expand at a 6.33% CAGR as hospitals strengthen interventional cardiology capabilities, improve access to specialized cardiac care, and increase adoption of minimally invasive valve replacement procedures.
Segment Momentum
- Adults accounted for 64.41% of the market in 2026 due to a larger treated patient base and established interventional workflows that support repeat valve procedures for right ventricular outflow tract disorders.
- Synthetic materials are gaining traction because they offer greater durability potential, manufacturing consistency, and design control, supporting the development of more standardized next-generation transcatheter pulmonary valves.
Market Expansion Drivers
- Increasing prevalence of cardiovascular and congenital heart diseases driving valve replacement procedure volumes.
- Advancements in imaging-guided cardiac interventions improving transcatheter pulmonary valve implantation outcomes.
- Rising awareness campaigns and government heart health initiatives supporting early cardiovascular intervention adoption.
Leading Market Participants
- Prominent players in the transcatheter pulmonary valve market include Medtronic plc (Ireland), Edwards Lifesciences Corporation (United States), Boston Scientific Corporation (United States), Artivion, Inc. (United States), Venus Medtech (Hangzhou) Inc. (China), Lepu Medical Technology (Beijing) Co., Ltd. (China), LivaNova PLC (United Kingdom), Braile Biomedica (Brazil), Abbott Laboratories (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 80.8 million
- 2027 Estimated Market Size: USD 84.36 million.
- Projected Market Size: USD 134.53 million by 2036
- Growth Forecast: 5.23% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Adult (End-use) | Tissue Engineered (Raw Material) | Balloon Expanded Transcatheter Valve (Technology) | Pulmonary Stenosis (Application)
- Emerging Opportunity Segment: Pediatric (End-use) | Synthetic (Raw Material) | Self Expanded Transcatheter Valve (Technology) | Pulmonary Regurgitation (Application)
Market Growth Drivers and Industry Trends
Increasing prevalence of cardiovascular and congenital heart diseases driving valve replacement procedure volumes
Increasing cardiovascular and congenital heart disease prevalence will drive the transcatheter pulmonary valve market by raising the need for valve replacement procedures among affected patients. Greater clinical demand for pulmonary valve interventions supports the use of transcatheter approaches, particularly where patients require valve replacement as part of ongoing management of structural or cardiovascular conditions.
Advancements in imaging-guided cardiac interventions improving transcatheter pulmonary valve implantation outcomes
Advances in imaging-guided cardiac procedures are strengthening the transcatheter pulmonary valve market by improving procedural guidance and supporting more precise valve implantation. Better visualization during interventions can assist clinicians in positioning and deploying pulmonary valves, contributing to greater confidence in transcatheter procedures and supporting their integration into contemporary cardiac treatment practices.
Rising awareness campaigns and government heart health initiatives supporting early cardiovascular intervention adoption
Government heart health initiatives and awareness campaigns will propel the transcatheter pulmonary valve market by encouraging greater recognition of cardiovascular conditions and the importance of timely intervention. Increased awareness can support earlier engagement with healthcare services, while public health efforts reinforce the need for appropriate cardiovascular evaluation and treatment, creating greater consideration of minimally invasive valve replacement options.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing prevalence of cardiovascular and congenital heart diseases driving valve replacement procedure volumes | 1.80% | High | North America, Europe, Asia Pacific | High | Near Term |
| Advancements in imaging-guided cardiac interventions improving transcatheter pulmonary valve implantation outcomes | 1.60% | High | North America, Europe | Medium | Mid Term |
| Rising awareness campaigns and government heart health initiatives supporting early cardiovascular intervention adoption | 1.30% | High | Asia Pacific, Latin America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America led the transcatheter pulmonary valve market with the largest share in 2026, supported by advanced cardiovascular care infrastructure, high availability of specialized cardiac centers, and established expertise in catheter-based interventions. The region's strong focus on treating congenital and structural heart conditions is creating demand for less invasive alternatives to conventional surgical procedures, particularly among patients requiring pulmonary valve replacement. Continued investment in advanced imaging, interventional cardiology capabilities, and specialized cardiac care is facilitating broader clinical adoption. Favorable physician familiarity with transcatheter techniques and growing emphasis on reducing procedural burden are further strengthening North America's market leadership.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is positioned as the fastest-growing regional market, driven by improving cardiac care infrastructure, expanding access to specialized interventions, and rising recognition of congenital and structural heart disorders. Healthcare investments are enabling more hospitals to develop advanced interventional capabilities, while improvements in diagnostic imaging are supporting earlier identification and assessment of patients who may benefit from transcatheter procedures. Increasing medical expertise in catheter-based therapies and growing patient preference for less invasive treatment approaches are also contributing to adoption. As healthcare systems continue to strengthen specialized cardiovascular services, the region is expected to provide substantial opportunities for transcatheter pulmonary valve technologies.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Advanced Cardiac ProceduresGermany prioritizes transcatheter pulmonary valve technologies that complement sophisticated interventional cardiology practices. Clinical adoption is supported by experienced heart centers focused on improving procedural precision and long-term patient outcomes.
France 🇫🇷
Minimally Invasive CardiologyFrance supports wider integration of transcatheter pulmonary valves as clinicians seek less invasive treatment alternatives. Cardiac specialists prioritize technologies that improve procedural efficiency while maintaining durable valve performance.
Italy 🇮🇹
Specialized Valve ProgramsItaly is strengthening specialized cardiac programs that incorporate transcatheter pulmonary valve procedures for selected patients. Demand reflects growing clinical interest in reducing surgical burden while enhancing long-term treatment effectiveness.
Japan 🇯🇵
Specialized Congenital CareJapan continues to strengthen the use of transcatheter pulmonary valves within specialized congenital heart disease programs. Healthcare providers emphasize minimally invasive treatment options that improve procedural safety and patient recovery.
South Korea 🇰🇷
Interventional Cardiology ExpansionSouth Korea is expanding transcatheter pulmonary valve adoption through investments in advanced cardiovascular care and catheter-based therapies. Medical centers increasingly evaluate devices based on procedural reliability and compatibility with complex cardiac interventions.
United States 🇺🇸
Structural Heart InnovationThe U.S. transcatheter pulmonary valve market is supported by expanding structural heart programs and specialized cardiac centers. Physicians increasingly adopt minimally invasive valve replacement approaches that reduce recovery time for eligible congenital heart disease patients.
Segment Leadership and Growth Trends
Transcatheter Pulmonary Valve Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Adult (Largest Segment) vs Pediatric (Fastest-Growing Segment)
The adult segment dominated the transcatheter pulmonary valve market with a 64.41% share in 2026, supported by the substantial need for pulmonary valve interventions among adult patients with congenital and acquired cardiac conditions. Transcatheter approaches offer less invasive treatment options compared with conventional open-heart procedures, supporting their use among patients where reduced procedural burden and recovery time are important considerations. Growing clinical acceptance of catheter-based valve replacement and continued emphasis on minimally invasive cardiac care are reinforcing the segment's leading position.
The pediatric patient segment is gaining momentum as clinicians increasingly seek less invasive approaches for children requiring pulmonary valve intervention. Transcatheter procedures can help reduce surgical trauma and support treatment strategies tailored to younger patients with congenital heart conditions. Increasing attention to preserving cardiac function, reducing repeat surgical burden, and improving long-term management of pediatric cardiac patients is contributing to stronger adoption of transcatheter pulmonary valve technologies.
Raw Material Segment Analysis: Tissue Engineered (Largest Segment) vs Synthetic (Fastest-Growing Segment)
In the transcatheter pulmonary valve market, the tissue engineered segment held the largest share of 62.06% in 2026, reflecting the importance of biologically compatible valve materials in supporting effective hemodynamic performance and patient outcomes. Tissue-engineered materials can provide characteristics suited to physiological interaction and valve functionality, making them attractive for transcatheter pulmonary valve applications. Continued development of biologically oriented valve technologies and clinical focus on durability and compatibility are supporting the segment's established position.
Synthetic materials are emerging as a faster-growing alternative as manufacturers and clinicians pursue greater control over material characteristics, consistency, and device performance. Advances in material engineering are enabling the development of synthetic components with improved flexibility, durability, and compatibility with minimally invasive delivery systems. Increasing demand for predictable device properties and continued innovation in transcatheter valve design are creating favorable conditions for wider use of synthetic raw materials.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Adult, Pediatric | Adult | Pediatric |
| Raw Material | Synthetic, Tissue Engineered | Tissue Engineered | Synthetic |
| Technology | Balloon Expanded Transcatheter Valve, Self Expanded Transcatheter Valve | Balloon Expanded Transcatheter Valve | Self Expanded Transcatheter Valve |
| Application | Pulmonary Stenosis, Pulmonary Regurgitation, Pulmonary Atresia, Others | Pulmonary Stenosis | Pulmonary Regurgitation |
Competitive Landscape and Market Positioning
Leading companies in the transcatheter pulmonary valve market:
1. Medtronic plc (Ireland)
2. Edwards Lifesciences Corporation (United States)
3. Boston Scientific Corporation (United States)
4. Artivion Inc. (United States)
5. Venus Medtech (Hangzhou) Inc. (China)
6. Lepu Medical Technology (Beijing) Co. Ltd. (China)
7. LivaNova PLC (United Kingdom)
8. Braile Biomedica (Brazil)
9. Abbott Laboratories (United States)
In the transcatheter pulmonary valve market, progress is being shaped by continuous refinement of minimally invasive cardiac solutions aimed at improving procedural precision and patient outcomes. Innovation cycles are strongly driven by advancements in valve design and delivery systems, enabling more adaptable clinical applications. Alongside this, collaborative development efforts and sustained research focus are accelerating the evolution of next-generation therapeutic options in structural heart care.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Edwards Lifesciences Corporation (United States) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| Artivion Inc. (United States) | |||||||
| Venus Medtech (Hangzhou) Inc. (China) | |||||||
| Lepu Medical Technology (Beijing) Co. Ltd. (China) | |||||||
| LivaNova PLC (United Kingdom) | |||||||
| Braile Biomedica (Brazil) | |||||||
| Abbott Laboratories (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Iris Valve | Jun-25 | Iris Valve announced positive early-stage preclinical testing results for its novel transcatheter heart valve technology tailored for very young children with congenital cardiac defects. The data indicates potential for future therapeutic expansion, addressing a specific unmet clinical need in the pediatric patient population through minimally invasive procedural approaches. |
| Medtronic plc | Jan-25 | Medtronic received CE Mark approval for its Harmony Transcatheter Pulmonary Valve system, facilitating expanded access to minimally invasive therapy across the European Union. This regulatory milestone supports broader treatment availability for patients with congenital heart disease and strengthens the company's competitive position within the transcatheter pulmonary valve replacement market. |
| HonorHealth | Dec-24 | HonorHealth integrated the Medtronic Harmony Transcatheter Pulmonary Valve Therapy into its service portfolio at Shea Medical Center. This facility-level expansion broadens regional access to advanced, minimally invasive pulmonary valve replacement options for adult patients, reflecting increased clinical adoption and infrastructure support for specialized structural heart interventions. |
| Venus Medtech Inc. | Jun-24 | Venus Medtech completed an implantation of its VenusP-Valve transcatheter pulmonic valve replacement system as part of the pivotal PROTEUS investigational device exemption clinical study. This progress signifies continued efforts to advance clinical validation and regulatory pathway progression for the company's proprietary valve technology in the pulmonary segment. |
| Medtronic plc | Feb-23 | Medtronic relaunched the Harmony Transcatheter Pulmonary Valve System for the treatment of congenital heart disease and secured subsequent regulatory approval in Japan. The expansion into the Japanese market represents a significant step in the company's global commercialization strategy for its minimally invasive structural heart portfolio. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Transcatheter Pulmonary Valve Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Valve Size | Small-Diameter Valves, Medium-Diameter Valves, Large-Diameter Valves |
| Implantation Access Route | Femoral Venous Access, Jugular Venous Access, Other Venous Access Routes |
| Hospital Ownership | Public Hospitals, Private Hospitals, Academic & Teaching Hospitals |
Transcatheter Pulmonary Valve Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Procedure Adoption Forecast Analysis |
|
| Patient Selection and Treatment Pathway Review |
|
| Clinical Innovation Opportunity Mapping |
|
Need a different cut of the data?
Request Custom ResearchHow big is the transcatheter pulmonary valve market?
What is the anticipated CAGR of the transcatheter pulmonary valve industry?
How are advances in imaging technologies supporting adoption in the transcatheter pulmonary valve market?
Why is demand for less invasive valve replacement increasing in the transcatheter pulmonary valve market?
Why is the Adult segment leading the transcatheter pulmonary valve market?
Why are Synthetic materials the fastest-growing raw material segment?
Why is North America the largest transcatheter pulmonary valve market?
What is fueling transcatheter pulmonary valve market growth in Asia Pacific?
Who are the major participants shaping the transcatheter pulmonary valve landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization